MicroScan Dried Gram-Negative MIC/Combo Panels with Ciprofloxacin-S (0.004 – 8 µg/mL)

FDA 510(k) K172912 · Beckman Coulter, Inc.

Substantially Equivalent

510(k) numberK172912

Submission

Device name
MicroScan Dried Gram-Negative MIC/Combo Panels with Ciprofloxacin-S (0.004 – 8 µg/mL)
Applicant
Beckman Coulter, Inc.
West Sacramento, CA, US
Received
September 25, 2017
Decision date
December 7, 2017
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
LTT – Panels, Test, Susceptibility, Antimicrobial
Device class
Class II (moderate risk)
Regulation
21 CFR 866.1640
Specialty
Microbiology

Other 510(k)s with product code LTT

510(k)DeviceApplicantDecision
K243804MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL)…LTT · Traditional Beckman Coulter, Inc.08/20/2025SE
K250036MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL)LTT · Traditional Beckman Coulter, Inc.08/15/2025SE
K250084MicroScan Dried Gram-Negative MIC/Combo Panels with Aztreonam (AZT) (0.5-64 µg/mL)LTT · Traditional Beckman Coulter, Inc.07/18/2025SE
K202343MicroScan Dried Gram-Negative MIC/Combo Panels with Ceftazidime (Caz) (0.5-64 µg/mL )LTT · Traditional Beckman Coulter, Inc.11/16/2020SE
K201423MicroScan Dried Gram-Negative MIC/Combo Panels with Meropenem (Mer) (0.004-32 µg/mL)LTT · Special Beckman Coulter, Inc.06/29/2020SE
K193536MicroScan Dried Gram Negative MIC/Combo Panels with Ciprofloxacin (Cp) (0.004 - 8µg/mL)LTT · Traditional Beckman Coulter, Inc.03/18/2020SE
K193358MicroScan Dried Gram-Negative MIC/Combo Panels with Levofloxacin (Lvx) (0.008-16ug/mL)LTT · Traditional Beckman Coulter, Inc.03/03/2020SE
K183127MicroScan Dried Gram Negative MIC/Combo Panels with Meropenem/Vaborbactam…LTT · Traditional Beckman Coulter, Inc.02/12/2019SE
K172337MicroScan Dried Gram Negative MIC/Combo Panels with Ceftazidime/Avibactam (0.25/4 - 64/4…LTT · Traditional Beckman Coulter, Inc.12/15/2017SE
K172255MicroScan Dried Gram Negative MIC/Combo Panels with Ceftolozane/tazobactam (0.25/4 -…LTT · Traditional Beckman Coulter, Inc.12/01/2017SE

More from Beckman Coulter, Inc.

510(k)DeviceDecision
K252169Access BNP IINBC · Traditional 03/24/2026SE
K254059Access anti-HBc IgMSEI · Traditional 03/13/2026SE
K253687Access anti-HBc TotalSEI · Traditional 02/19/2026SE
K251995Access anti-HAV IgMLOL · Traditional 01/27/2026SE
K250588Access Rubella IgGLFX · Traditional 11/17/2025SE
K252580iQ200 SeriesLKM · Special 09/10/2025SE
K243846Access anti-HAVLOL · Traditional 09/09/2025SE
K243804MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL)…LTT · Traditional 08/20/2025SE
K250036MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL)LTT · Traditional 08/15/2025SE
K243483Access hsTnIMMI · Traditional 08/01/2025SE

Questions and answers

When was MicroScan Dried Gram-Negative MIC/Combo Panels with Ciprofloxacin-S (0.004 – 8 µg/mL) cleared by the FDA?

MicroScan Dried Gram-Negative MIC/Combo Panels with Ciprofloxacin-S (0.004 – 8 µg/mL) (K172912) received a 510(k) decision of Substantially Equivalent on December 7, 2017, 73 days after the submission was received.

What is the product code of K172912?

The FDA product code is LTT – Panels, Test, Susceptibility, Antimicrobial, a Class II (moderate risk) device regulated under 21 CFR 866.1640.